Dapsone
- Product NDC
- 43353-223
- 11-digit product format
- 433530223
- Labeler code
- 43353
- Product ID
- 43353-223_26c902cb-733e-4dcb-9a47-f5044956a503
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dapsone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA204074
- Marketing category
- ANDA
- Marketing start
- 2016-06-01
- Marketing end
- 0000-00-00
- Substance
- DAPSONE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Sulfone [EPC],Sulfones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-223 | DAPSONE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 4 | Legacy NDC | 20171026_8eafb396-7564-48a0-80e8-4848341b73a1.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-223-30 | 43353022330 | 30 TABLET in 1 BOTTLE (43353-223-30) | 30 tablet | 2016-08-29 | 0000-00-00 | No | No | Current |